Paper
Brain met-enkephalin immunostaining after subacute and subchronic exposure to benzene
Published 1994 · J. Gandarias, E. Echevarría, F. Martínez-García
Bulletin of Environmental Contamination and Toxicology
2
Citations
0
Influential Citations
Abstract
Benzene is used in a wide variety of domestic and occupational activities, and due to its lipophilic nature, it accumulates in lipid-rich tissues like the brain. In this sense, neurotoxic action has long been associated with organic solvent exposure and it has been shown that benzene, injected in a single dose or during a prolongued administration, modifies the content of dopamine, noradrenaline, serotonin and its main metabolite 5-hydroxy indolacetic acid, in several brain regions of the rat, then revealing a stimulating action on brain monoamine synthesis and turnover. However, information concerning neurotoxic action of benzene exposure in vivo on peptidergic neuromodulatory systems is still lacking. Nevertheless, it has been recently described that subacute benzene exposure in rats generates regional changes in brain aminopeptidase activity. These proteolytic enzymes have been widely associated with metabolic control of neuropeptides and it has been suggested that they could play a role in benzene neurotoxic mechanism by hypothetically changing regional neuropeptide levels. This being the case, we focused on analyzing met-enkephalin immunostaining in different brain regions of the rat after subacute and subchronic administration of benzene. 12 refs., 3 figs.
Subacute and subchronic exposure to benzene in rats leads to regional changes in met-enkephalin immunostaining, suggesting a potential neurotoxic mechanism.
Full text analysis coming soon...